In summary, this study demonstrated that Gab2 is a cancer-associated protein that plays an oncogenic role in hepatocellular carcinogenesis by integrating multiple signaling pathways, especially those that are modulated by inflammatory factors; therefore, the signaling adaptor protein, Gab2, may be a powerful, novel target for the prevention and treatment of liver cancer. This evidence concerns the gene GAB2 and liver cancer.